CRNX
Price
$31.08
Change
-$0.03 (-0.10%)
Updated
Jul 21, 03:56 PM (EDT)
Capitalization
2.91B
17 days until earnings call
ZURA
Price
$1.88
Change
-$0.03 (-1.57%)
Updated
Jul 21, 10:54 AM (EDT)
Capitalization
118.18M
Interact to see
Advertisement

CRNX vs ZURA

Header iconCRNX vs ZURA Comparison
Open Charts CRNX vs ZURABanner chart's image
Crinetics Pharmaceuticals
Price$31.08
Change-$0.03 (-0.10%)
Volume$400
Capitalization2.91B
Zura Bio
Price$1.88
Change-$0.03 (-1.57%)
Volume$1.16K
Capitalization118.18M
CRNX vs ZURA Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ZURA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and ZURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CRNX: $31.11 vs. ZURA: $1.91)
Brand notoriety: CRNX and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 123% vs. ZURA: 424%
Market capitalization -- CRNX: $2.91B vs. ZURA: $118.18M
CRNX [@Biotechnology] is valued at $2.91B. ZURA’s [@Biotechnology] market capitalization is $118.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 6 TA indicator(s) are bullish while ZURA’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 6 bullish, 4 bearish.
  • ZURA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ZURA.

Price Growth

CRNX (@Biotechnology) experienced а -2.57% price change this week, while ZURA (@Biotechnology) price change was +45.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.54%. For the same industry, the average monthly price growth was +15.96%, and the average quarterly price growth was +34.77%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.91B) has a higher market cap than ZURA($118M). ZURA YTD gains are higher at: -23.600 vs. CRNX (-39.155). ZURA has higher annual earnings (EBITDA): -66.05M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ZURA (171M). CRNX has higher revenues than ZURA: CRNX (760K) vs ZURA (0).
CRNXZURACRNX / ZURA
Capitalization2.91B118M2,469%
EBITDA-373.49M-66.05M566%
Gain YTD-39.155-23.600166%
P/E RatioN/A7.96-
Revenue760K0-
Total Cash1.27B171M745%
Total Debt50.8MN/A-
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXZURA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
43%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
58%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
50%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
43%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
40%
Aroon
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 7 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZVGIX59.070.21
+0.36%
Zevenbergen Genea Institutional
FTXAX44.650.07
+0.16%
FullerThaler Behavioral Sm-Cp Gr A
GEIYX17.670.01
+0.06%
GuideStone Funds Growth Equity Idx Instl
MJRFX23.450.01
+0.04%
BlackRock Mid-Cap Value K
ALLIX117.06-0.38
-0.32%
AB Large Cap Growth I

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-5.78%
XNCR - CRNX
61%
Loosely correlated
-1.10%
IDYA - CRNX
59%
Loosely correlated
-2.26%
TRDA - CRNX
57%
Loosely correlated
-1.88%
RVMD - CRNX
56%
Loosely correlated
-1.92%
KRYS - CRNX
56%
Loosely correlated
-1.77%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with SYRE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-2.55%
SYRE - ZURA
45%
Loosely correlated
-3.55%
CCCC - ZURA
44%
Loosely correlated
+6.42%
CRNX - ZURA
43%
Loosely correlated
-5.78%
RXRX - ZURA
42%
Loosely correlated
+5.80%
NRIX - ZURA
42%
Loosely correlated
-7.28%
More